Science Explorer Interactive view Map
Company · Seoul · South Korea

Pfizer (South Korea)

pfizer.co.krROR OpenAlex
Research works
50
▼ 23% vs 2013–17
Citations
468
9.4 per fractional work
Top-10% rate
18.8%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Pfizer (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.00× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.79× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.69× its world share, 0 worksPharmacology, Toxico…Mathematics: 0.39× its world share, 0 worksMathematicsHealth Professions: 0.66× its world share, 0 worksHealth ProfessionsMedicine: 3.28× its world share, 5 worksMedicineDecision Sciences: 6.45× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.76× its world share, 0 worksEconomics, Econometr…Psychology: 5.12× its world share, 1 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 6.5×. Every wedge is a field page.

Which keywords describe research at Pfizer (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Clinical Practice Guidelines, Risk Factors, Cardiovascular Risk and Global Burden.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology9▲ 4.5×38 topics
  2. Quality of Life7▲ 10.0×13 topics
  3. Cost-effectiveness Analysis4▲ 108×1 topic
  4. Health Utility Measures4▲ 108×1 topic
  5. Clinical Practice Guidelines4▲ 13×9 topics
  6. Risk Factors4▲ 7.0×10 topics
  7. Inflammation3▲ 2.9×10 topics
  8. Cardiovascular Risk3▲ 16×4 topics
  9. Global Burden3▲ 10.0×4 topics
  10. Autoantibodies2▲ 19×4 topics
  11. Rheumatoid Arthritis2▲ 38×3 topics
  12. Treatment2▲ 3.0×10 topics
  13. Antimicrobial Resistance2▲ 14×3 topics
  14. Depression2▲ 4.8×7 topics
  15. Prophylaxis2▲ 26×3 topics
  16. Biological Therapy2▲ 62×1 topic
  17. Cardiovascular Disease Prevention2▲ 45×2 topics
  18. Chemotherapy2▲ 4.8×9 topics
  19. Disease-Modifying Antirheumatic Drugs2▲ 70×1 topic
  20. Community-Acquired Pneumonia2▲ 79×1 topic
  21. Hypertension2▲ 9.0×4 topics
  22. Pneumococcal Conjugate Vaccine2▲ 79×1 topic
  23. Clinical Trials2▲ 5.0×8 topics
  24. Health Services2▲ 44×2 topics
  25. Chronic Disease Management1▲ 19×2 topics
  26. Intraocular Pressure1▲ 28×2 topics
  27. Medication Adherence1▲ 48×2 topics
  28. Prevalence1▲ 7.2×2 topics
  29. Stigma1▲ 25×2 topics
  30. Tumor Microenvironment1▲ 7.8×4 topics
  31. Cardiovascular Events1▲ 16×3 topics
  32. Clinical Guidelines1▲ 8.7×3 topics
  33. Help-Seeking Behavior1▲ 63×1 topic
  34. Mental Disorders1▲ 27×2 topics
  35. Patient Compliance1▲ 128×1 topic
  36. Public Attitudes1▲ 63×1 topic
  37. Treatment Adherence1▲ 128×1 topic
  38. Metastatic Breast Cancer1▲ 36×2 topics
  39. Retinal Ganglion Cells1▲ 18×3 topics
  40. Targeted Therapy1▲ 11×4 topics

Which research topics does Pfizer (South Korea) publish most on?

By volume in 2022–2025: Mental Health Treatment and Access, Risk and Safety Analysis, Rheumatoid Arthritis Research and Therapies and Atrial Fibrillation Management and Outcomes.

Mental Health Treatment …1Mental Health Treatment and Access: 1 fractional worksRisk and Safety Analysis0Risk and Safety Analysis: 0 fractional worksRheumatoid Arthritis Res…0Rheumatoid Arthritis Research and Therapies: 0 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksPneumonia and Respiratory Infections: 0 fractional worksAutoimmune and Inflammat…0Autoimmune and Inflammatory Disorders Research: 0 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional worksRespiratory viral infections research: 0 fractional worksSmoking Behavior and Cessation: 0 fractional worksImmune responses and vaccinations: 0 fractional works
Social PsychologyStatistics, Probability and UncertaintyRheumatologyCardiology and Cardiovascular Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Mental Health Treatment and Access Social Psychology 1 works
  2. 2 Risk and Safety Analysis Statistics, Probability and Uncertainty 0 works
  3. 3 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  4. 4 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  5. 5 Pneumonia and Respiratory Infections Epidemiology 0 works
  6. 6 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  7. 7 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  8. 8 Respiratory viral infections research Epidemiology 0 works
  9. 9 Smoking Behavior and Cessation Physiology 0 works
  10. 10 Immune responses and vaccinations Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.3%not open50.7%

World: 28% of research is openly available.

with international co-authors24.4%domestic only75.6%

World: 19% is written across borders.

How has Pfizer (South Korea)'s research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.